Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment

Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment

A 45-year-old Italian woman, affected by relapsing−remitting multiple sclerosis (RR-MS) starting from 2011, started treatment with alemtuzumab in July 2016. Nine months after the second infusion, she had an immune thrombocytopenic purpura (ITP) with complete recovery after steroid treatmen...

Full description

Bibliographic Details
Main Authors: Maria Chiara Buscarinu, Arianna Fornasiero, Giulia Pellicciari, Roberta Reniè, Anna Chiara Landi, Alessandro Bozzao, Cristina Cappelletti, Pia Bernasconi, Giovanni Ristori, Marco Salvetti
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Brain Sciences
Subjects:
multiple sclerosis
autoimmune diseases
immune thrombocytopenic purpura
autoimmune encephalitis
alemtuzumab
antibodies against glur3 peptide
Online Access:https://www.mdpi.com/2076-3425/9/11/299

Internet

https://www.mdpi.com/2076-3425/9/11/299

Similar Items